198 related articles for article (PubMed ID: 2044333)
1. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
[TBL] [Abstract][Full Text] [Related]
2. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
[TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
Mandema JW; Tukker E; Danhof M
J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
Lu JF; Chen G; Xiang BR; An DK
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and EEG effects of flumazenil in volunteers.
Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
Clin Pharmacokinet; 1991 Jun; 20(6):491-6. PubMed ID: 2044332
[TBL] [Abstract][Full Text] [Related]
7. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
[TBL] [Abstract][Full Text] [Related]
8. Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal.
Schnider TW; Minto CF; Fiset P; Gregg KM; Shafer SL
Anesthesiology; 1996 Mar; 84(3):510-9. PubMed ID: 8659777
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteers.
Zhi J; Massarella JW; Melia AT; Teller SB; Schmitt-Muskus J; Crews T; Oldfield N; Erb RJ; Leese PT; Patel IH
Clin Pharmacol Ther; 1994 Nov; 56(5):530-6. PubMed ID: 7955817
[TBL] [Abstract][Full Text] [Related]
10. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
Ebert U; Oertel R; Kirch W
Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
[TBL] [Abstract][Full Text] [Related]
11. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
Mandema JW; Tukker E; Danhof M
Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
[TBL] [Abstract][Full Text] [Related]
13. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of flumazenil and midazolam.
Jones RD; Chan K; Roulson CJ; Brown AG; Smith ID; Mya GH
Br J Anaesth; 1993 Mar; 70(3):286-92. PubMed ID: 8471371
[TBL] [Abstract][Full Text] [Related]
15. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
Mandema JW; Kuck MT; Danhof M
J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
[TBL] [Abstract][Full Text] [Related]
16. Midazolam and flumazenil pharmacokinetics and pharmacodynamics following simultaneous administration to human volunteers.
Short TG; Young KK; Tan P; Tam YH; Gin T; Oh TE
Acta Anaesthesiol Scand; 1994 May; 38(4):350-6. PubMed ID: 8067222
[TBL] [Abstract][Full Text] [Related]
17. Modelling acute tolerance to the EEG effect of two benzodiazepines.
Ihmsen H; Albrecht S; Hering W; Schüttler J; Schwilden H
Br J Clin Pharmacol; 2004 Feb; 57(2):153-61. PubMed ID: 14748814
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
[TBL] [Abstract][Full Text] [Related]
19. The rate of CSF formation, resistance to reabsorption of CSF, and aperiodic analysis of the EEG following administration of flumazenil to dogs.
Artru AA
Anesthesiology; 1990 Jan; 72(1):111-7. PubMed ID: 2105064
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
Tuk B; van Gool T; Danhof M
J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
